Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: A randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine

David Osoba, Donald W. Northfelt, David W. Budd, David Himmelberger

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

The purpose of this study was to determine whether health-related quality of life (HRQL) would be improved in patients with acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma treated by pegylated-liposomal doxorubicin (PLD) as compared to those treated by a conventional combination of doxorubicin, bleomycin, and vincristine (ABV). One hundred thirty-three patients received PLD and 125 patients received ABV every 2 weeks with a planned total of 6 cycles. Patients completed a 30-item AIDS-related HRQL questionnaire before beginning treatment (baseline), every 2 weeks while on treatment, and about 21 days after the end of treatment. Twenty-two items, involving nine domains, were analyzable. While on treatment, PLD-treated patients with partial clinical responses achieved statistically significant greater improvement (compared to baseline) in general health than did ABV-treated patients with partial clinical responses (p = 0.008). By the end of treatment, the overall group of patients receiving PLD showed statistically significant greater improvement in pain and energy/fatigue than did the group receiving ABV (p = 0.01-0.002). In addition, duration of clinically significant improvement in global QL was longer in the PLD arm.

Original languageEnglish (US)
Pages (from-to)573-580
Number of pages8
JournalCancer Investigation
Volume19
Issue number6
DOIs
StatePublished - Aug 4 2001

Keywords

  • Acquired immunodeficiency syndrome (AIDS)
  • Bleomycin
  • Doxorubicin
  • Health-related quality of life
  • Kaposi's sarcoma
  • Pegylated-liposomal doxorubicin
  • Vincristine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: A randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine'. Together they form a unique fingerprint.

  • Cite this